uMed

uMed is a London-based healthcare technology company founded in 2018.

It focuses on accelerating life science research by automating patient recruitment and connecting consented patients with clinical studies through its ACCESS Research Platform. This platform integrates electronic health records, patient-generated data, clinical outcomes, and biosamples to create tailored datasets for research. The company offers a B2B technology platform that serves life science companies, healthcare institutions, and researchers. Key services include automated patient recruitment, the creation of consented patient cohorts, real-world evidence generation, and clinical trial support. uMed's solutions help address challenges in clinical trials, such as high screen-failure rates and slow recruitment speeds. With a team of approximately 11–50 employees, uMed is headquartered in London and has additional offices in New York and Cambridge, MA.